Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea

References

• CassanoGRoveranoSPairaSAccrual of organ damage over time in Argentine patients with systemic lupus erythematosus: a multicentre studyClin Rheumatol200726122017202217415506
   PubMed Web of Science ®Google Scholar
• ChakravartyEFBushTMManziSClarkeAEWardMMPrevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization dataArthritis Rheum20075662092209417530651
   PubMed Web of Science ®Google Scholar
• Pons-EstelGJAlarcónGSScofieldLReinlibLCooperGSUnderstanding the epidemiology and progression of systemic lupus erythematosusSemin Arthritis Rheum201039425726819136143
   PubMed Web of Science ®Google Scholar
• ShimJSSungYKJooYBLeeHSBaeSCPrevalence and incidence of systemic lupus erythematosus in South KoreaRheumatol Int201434790991724322455
   PubMed Web of Science ®Google Scholar
• LauCSMakAThe socioeconomic burden of SLENat Rev Rheumatol20095740040419506585
   PubMed Web of Science ®Google Scholar
• SlawskyKAFernandesAWFusfeldLManziSGossTFA structured literature review of the direct costs of adult systemic lupus erythematosus in the USArthritis Care Res (Hoboken)20116391224123221584945
   PubMed Web of Science ®Google Scholar
• Von FeldtJMSystemic lupus erythematosus. Recognizing its various presentationsPostgrad Med1995974798386 passim7716094
   PubMed Web of Science ®Google Scholar
• FesslerBJBoumpasDTSevere major organ involvement in systemic lupus erythematosus. Diagnosis and managementRheum Dis Clin North Am199521181987732176
   PubMed Web of Science ®Google Scholar
• FiroozNAlbertDAWallaceDJIshimoriMBerelDWeismanMHHigh-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosusLupus201120658859721436216
   PubMed Web of Science ®Google Scholar
• GaitondeSSamolsDKushnerIC-reactive protein and systemic lupus erythematosusArthritis Rheum200859121814182019035410
   PubMed Web of Science ®Google Scholar
• Gamez-NavaJIGonzalez-LopezLDavisPSuarez-AlmazorMEReferral and diagnosis of common rheumatic diseases by primary care physiciansBr J Rheumatol19983711121512199851272
   PubMedGoogle Scholar
• BertsiasGIoannidisJPBoletisJTask Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsEULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsAnn Rheum Dis200867219520517504841
   PubMed Web of Science ®Google Scholar
• van VollenhovenRFMoscaMBertsiasGTreat-to-target in systemic lupus erythematosus: recommendations from an international task forceAnn Rheum Dis201473695896724739325
   PubMed Web of Science ®Google Scholar
• BorchersATKeenCLShoenfeldYGershwinMESurviving the butterfly and the wolf: mortality trends in systemic lupus erythematosusAutoimmun Rev20043642345315351310
   PubMed Web of Science ®Google Scholar
• BonguAChangERamsey-GoldmanRCan morbidity and mortality of SLE be improved?Best Pract Res Clin Rheumatol200216231333212041956
   PubMed Web of Science ®Google Scholar
• KimJYLeeJKoYJMulti-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based studyPLoS One2013812e8384924391836
   PubMed Web of Science ®Google Scholar
• XiongWLahitaRGPragmatic approaches to therapy for systemic lupus erythematosusNat Rev Rheumatol20141029710724166241
   PubMed Web of Science ®Google Scholar
• WallaceDJImproving the prognosis of SLE without prescribing lupus drugs and the primary care paradoxLupus2008172919218250130
   PubMed Web of Science ®Google Scholar
• VitaliCBencivelliWIsenbergDADisease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLEClin Exp Rheumatol19921055415471458710
   PubMed Web of Science ®Google Scholar
• Yildirim-TorunerCDiamondBCurrent and novel therapeutics in the treatment of systemic lupus erythematosusJ Allergy Clin Immunol20111272303312 quiz 313–31421281862
   PubMed Web of Science ®Google Scholar
• AkhavanPSSuJLouWGladmanDDUrowitzMBFortinPRThe early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosusJ Rheumatol201340683184123588942
   PubMed Web of Science ®Google Scholar
• JungHBobbaRSuJThe protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosusArthritis Rheum201062386386820131232
   PubMed Web of Science ®Google Scholar
• Pons-EstelGJAlarcónGSGonzalezLALumina Study GroupPossible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohortArthritis Care Res (Hoboken)201062339340020391486
   PubMed Web of Science ®Google Scholar
• DoriaABrianiCLupus: improving long-term prognosisLupus200817316617018372355
   PubMed Web of Science ®Google Scholar
• WallaceDJAntimalarials – the ‘real’ advance in lupusLupus200110638538711434570
   PubMed Web of Science ®Google Scholar
• HoKTAhnCWAlarcónGSSystemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic eventsRheumatology (Oxford)200544101303130716030085
   PubMed Web of Science ®Google Scholar
• LakshminarayananSWalshSMohanrajMRothfieldNFactors associated with low bone mineral density in female patients with systemic lupus erythematosusJ Rheumatol200128110210811196509
   PubMed Web of Science ®Google Scholar
• MoladYGorshteinAWysenbeekAJProtective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohortLupus200211635636112139373
   PubMed Web of Science ®Google Scholar
• TamLSGladmanDDHallettDCRahmanPUrowitzMBEffect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosusJ Rheumatol20002792142214510990225
   PubMed Web of Science ®Google Scholar
• BelmontHMTreatment of systemic lupus erythematosus – 2013 updateBull Hosp Jt Dis (2013)201371320821324151947
   PubMedGoogle Scholar
• Ruiz-IrastorzaGRamos-CasalsMBrito-ZeronPKhamashtaMAClinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic reviewAnn Rheum Dis2010691202819103632
   PubMed Web of Science ®Google Scholar
• ApostolopoulosDHoiAYSystemic lupus erythematosus – when to consider and management optionsAust Fam Physician2013421069670024130970
   PubMedGoogle Scholar
• ContrerasGPardoVLeclercqBSequential therapies for proliferative lupus nephritisN Engl J Med20043501097198014999109
   PubMed Web of Science ®Google Scholar
• GinzlerEMDooleyMAAranowCMycophenolate mofetil or intravenous cyclophosphamide for lupus nephritisN Engl J Med2005353212219222816306519
   PubMed Web of Science ®Google Scholar
• NavarraSVGuzmánRMGallacherAEBLISS-52 Study GroupEfficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trialLancet2011377976772173121296403
   PubMed Web of Science ®Google Scholar
• van VollenhovenRFPetriMACerveraRBelimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of responseAnn Rheum Dis20127181343134922337213
   PubMed Web of Science ®Google Scholar
• Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus GuidelinesArthritis Rheum19994291785179610513791
   PubMedGoogle Scholar
• UrowitzMBKagalARahmanPGladmanDDRole of specialty care in the management of patients with systemic lupus erythematosusJ Rheumatol20022961207121012064836
   PubMed Web of Science ®Google Scholar
• MolinaMJMayorAMFrancoAEMorellCALópezMAViláLMUtilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto RicoEthn Dis2008182 Suppl 2S2-S205S210
   Google Scholar
• ViláLMAlarcónGSMcGwinGJrBastianHMFesslerBJReveilleJDLUMINA Study GroupSystemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrualJ Rheumatol200532112150215516265693
   PubMed Web of Science ®Google Scholar
• ZinkAFischer-BetzRThieleKGerman Collaborative Arthritis CentersHealth care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis CentresLupus200413752953615352425
   PubMed Web of Science ®Google Scholar